Gapping up
In reaction to strong earnings/guidance: AMSC +16.9%, FORD +7.2%, OLLI +6%, NSR +3.2%, (announces completion of MarketShare Partners acquisition and provides FY16 guidance ), GEF +2.3%, MNR +1.1%
M&A news: BLT +81.8% (to be acquired by affiliates of American Securities LLC and P2 Capital Partners for $10.00/share), LOJN +44.3% (CalAmp goes public with offer to acquire LoJack), GPRO +2.7% (mentioned as possible acq target for AAPL in FBR note), VLTC +1.3% ( to acquire all of Flanders Holding's right, title and interest in a real estate parcel located in Flanders, New York, for ~$2.8 mln)
Select metals/mining stocks trading higher: AU +6.5%, HMY +5.3%, GFI +0.8%, RIO +0.8%
Other news: QTNT +5.7% ( enters into a construction contract with MW High Tech Projects, for a new product development and manufacturing facility in Edinburgh, Scotland), XOMA +4.8% (entered into a settlement and amended license agreement with Pfizer (PFE), MNOV +3.9% (announced positive findings from a clinical trial of mn-166 in alcohol use disorder),PSEC +2.9% (following insider purhcases), RPTP +2.9% ( results from a Phase 2/3 clinical trial evaluating RP103 for the potential treatment of Huntington's disease, called CYST-HD), NVGN +2.8% (named James Garner as CEO effective February 1), CMG +2% (The NYPost speculates that the CDC could soon close its investigation of the E. coli investigation at Chipotle (CMG)), AMD +1.7% (still checking), SUNE +1.5% (announced that it has signed a 10-year agreement with Ontario's Independent Electricity System Operator)
Analyst comments: CYBR +3.5% (upgraded to Overweight from Underweight at JP Morgan), TREE +3.2% (upgraded to Buy from Neutral at BofA/Merrill), JCP +1.7% (upgraded to Neutral from Reduce at Nomura), TRMB +1.4% (initiated with an Outperform at Oppenheimer), NVCN +1.2% (initiated with a Buy at Ladenburg Thalmann), PRGO +1% (upgraded to Buy at Argus)
In reaction to strong earnings/guidance: AMSC +16.9%, FORD +7.2%, OLLI +6%, NSR +3.2%, (announces completion of MarketShare Partners acquisition and provides FY16 guidance ), GEF +2.3%, MNR +1.1%
M&A news: BLT +81.8% (to be acquired by affiliates of American Securities LLC and P2 Capital Partners for $10.00/share), LOJN +44.3% (CalAmp goes public with offer to acquire LoJack), GPRO +2.7% (mentioned as possible acq target for AAPL in FBR note), VLTC +1.3% ( to acquire all of Flanders Holding's right, title and interest in a real estate parcel located in Flanders, New York, for ~$2.8 mln)
Select metals/mining stocks trading higher: AU +6.5%, HMY +5.3%, GFI +0.8%, RIO +0.8%
Other news: QTNT +5.7% ( enters into a construction contract with MW High Tech Projects, for a new product development and manufacturing facility in Edinburgh, Scotland), XOMA +4.8% (entered into a settlement and amended license agreement with Pfizer (PFE), MNOV +3.9% (announced positive findings from a clinical trial of mn-166 in alcohol use disorder),PSEC +2.9% (following insider purhcases), RPTP +2.9% ( results from a Phase 2/3 clinical trial evaluating RP103 for the potential treatment of Huntington's disease, called CYST-HD), NVGN +2.8% (named James Garner as CEO effective February 1), CMG +2% (The NYPost speculates that the CDC could soon close its investigation of the E. coli investigation at Chipotle (CMG)), AMD +1.7% (still checking), SUNE +1.5% (announced that it has signed a 10-year agreement with Ontario's Independent Electricity System Operator)
Analyst comments: CYBR +3.5% (upgraded to Overweight from Underweight at JP Morgan), TREE +3.2% (upgraded to Buy from Neutral at BofA/Merrill), JCP +1.7% (upgraded to Neutral from Reduce at Nomura), TRMB +1.4% (initiated with an Outperform at Oppenheimer), NVCN +1.2% (initiated with a Buy at Ladenburg Thalmann), PRGO +1% (upgraded to Buy at Argus)